This Week at FDA: Drug Voucher Program Hits a Snag, GOP Targets Abortion Drug, and MoreJanuary 16, 2026January 17, 2026
FDA and EMA Release Guiding Principles of Good AI Practice in Drug DevelopmentJanuary 14, 2026January 14, 2026
This Week at FDA: FDA Eases Digital Health Oversight, MDUFA Negotiation Update, and MoreJanuary 9, 2026January 14, 2026
This Week at FDA: Anti-abortion Groups Want Makary Fired, FDA Investigating RSV VaccinesDecember 12, 2025December 13, 2025
Appointment of Controversial Official Rocking FDA Like “an atom bomb”December 8, 2025December 13, 2025
This Week at FDA: Makary Teases Plan for Single-Trial Drug Approvals, Høeg Named Acting CDER Chief, and MoreDecember 5, 2025December 6, 2025
